Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner Health Products’ reorganization

This article was originally published in The Tan Sheet

Executive Summary

OTC drug, dietary supplement private labeler's reorganization plan approved by Wilmington, Del. bankruptcy Judge Peter Walsh April 15. Prepackaged Chapter 11 filing, which previously received senior bank lender and bondholder approval, calls for restructuring current bank debt into two term loans totaling approximately $243 mil., plus a $20 mil. revolving credit facility. Senior subordinated note holders will receive $15 mil. cash and newly issued preferred stock in exchange for the notes (1"The Tan Sheet" March 11, 2000, p. 6)...

You may also be interested in...



Leiner Reorganization Plan Confirmation Hearing Slated For April

An April 15 hearing is scheduled for confirmation of Leiner Health Products' reorganization plan, filed Feb. 28 in Wilmington, Del. bankruptcy court

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel